Yüksel Ürün: Top Advances of the Year in Perioperative Therapy for Lung Cancer

Yüksel Ürün shared on X: .

“Top Advances of the Year: Perioperative Therapy for Lung Cancer

• In 2023, perioperative immune checkpoint inhibitors (ICIs) became a game-changer for early-stage non-small cell lung cancer (NSCLC)
• Despite these advances, optimizing patient selection and biomarker use remains a challenge”

Read further.
Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes.

His dedication to patient care and research inspires positive change in the medical field.